Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: Flip Side and UK

Posted by Abby on February 17, 2000, at 13:27:12

In reply to Re: FDA-Rebox. doesn't look too promising, posted by Leighwit on February 16, 2000, at 15:15:11

> I'm in the US and taking reboxetine through my Pdoc who orders it from a pharmacy in London. I consulted with a psychopharmacologist also before starting this drug.
>
> Drugs (at least those from the UK) without FDA involvement, have minimal labeling. You would not believe how vague the package insert is. Someone in the UK on reboxetine commented on another ng about how sophomoric the labeling information is on all of their drugs. "Pathetic" was the term I believe he used.
>
> I'm not defending the slow approval process by any means. But I do have a new appreciation for the information the FDA requires the pharmaceutical companies to provide to the public.
>
> I have juvenile-onset (Type I) insulin-dependent diabetes. The contraindications for ADs matter a great deal to all of us; particularly those with chronic medical conditions.
>
> If I lived in the UK, I'd be researching FDA information to make safe choices.
>
> Just some thoughts about the flip side of the coin.
>
> LW

UK labeling is rather patronizing and simplistic. I was on Lustral for a while, their name for Zoloft. I don't think that Europeans, and certainly not Britons, are any easier on drug manufacturers on truly substantive matters. We have i-dotting and t-crossing obsessed bureaucrats.
The UK has problems too. The chairman of Glaxo-Wellcome was threatening to abandon clinical trials and early launches there--too much work for the size of the market. To illustrate my point that the way we are harder on pharmaceutical firms is only so much paperwork production and not true safety concerns, I'll mention a drug which is approved for use here but not in the UK--bupropion (Wellbutrin).
A fair number of psychiatrists disagreed, but the UK regulatory body believed that the risk of seizure was too great. In that particular case, given the same data, they were "tougher" than our beloved FDA.

Abby


Share
Tweet  

Thread

 

Post a new follow-up

Your message only Include above post


[22055]

Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:Abby thread:21540
URL: http://www.dr-bob.org/babble/20000209/msgs/22055.html